BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33054056)

  • 1. RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS.
    Seibold M; Stühmer T; Kremer N; Mottok A; Scholz CJ; Schlosser A; Leich E; Holzgrabe U; Brünnert D; Barrio S; Kortüm MK; Solimando AG; Chatterjee M; Einsele H; Rosenwald A; Bargou RC; Steinbrunn T
    Haematologica; 2020 Sep; 105(9):2316-2326. PubMed ID: 33054056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer.
    Yan C; Theodorescu D
    Pharmacol Rev; 2018 Jan; 70(1):1-11. PubMed ID: 29196555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival.
    Steinbrunn T; Stühmer T; Gattenlöhner S; Rosenwald A; Mottok A; Unzicker C; Einsele H; Chatterjee M; Bargou RC
    Blood; 2011 Feb; 117(6):1998-2004. PubMed ID: 21149634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The B cell antigen receptor controls AP-1 and NFAT activity through Ras-mediated activation of Ral.
    de Gorter DJ; Vos JC; Pals ST; Spaargaren M
    J Immunol; 2007 Feb; 178(3):1405-14. PubMed ID: 17237388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth.
    Goi T; Rusanescu G; Urano T; Feig LA
    Mol Cell Biol; 1999 Mar; 19(3):1731-41. PubMed ID: 10022860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
    Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAL GTPases mediate EGFR-driven intestinal stem cell proliferation and tumourigenesis.
    Nászai M; Bellec K; Yu Y; Román-Fernández A; Sandilands E; Johansson J; Campbell AD; Norman JC; Sansom OJ; Bryant DM; Cordero JB
    Elife; 2021 Jun; 10():. PubMed ID: 34096503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential fMet-Leu-Phe- and platelet-activating factor-induced signaling toward Ral activation in primary human neutrophils.
    M'Rabet L; Coffer PJ; Wolthuis RM; Zwartkruis F; Koenderman L; Bos JL
    J Biol Chem; 1999 Jul; 274(31):21847-52. PubMed ID: 10419502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of R-Ras and Ral GTPases in estrogen-independent proliferation of breast cancer cells.
    Yu Y; Feig LA
    Oncogene; 2002 Oct; 21(49):7557-68. PubMed ID: 12386818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21.
    Rosário M; Paterson HF; Marshall CJ
    Mol Cell Biol; 2001 Jun; 21(11):3750-62. PubMed ID: 11340168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ral activation promotes melanomagenesis.
    Zipfel PA; Brady DC; Kashatus DF; Ancrile BD; Tyler DS; Counter CM
    Oncogene; 2010 Aug; 29(34):4859-64. PubMed ID: 20562921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ral GTPases: crucial mediators of exocytosis and tumourigenesis.
    Shirakawa R; Horiuchi H
    J Biochem; 2015 May; 157(5):285-99. PubMed ID: 25796063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras-dependent activation of the small GTPase Ral.
    Wolthuis RM; Zwartkruis F; Moen TC; Bos JL
    Curr Biol; 1998 Apr; 8(8):471-4. PubMed ID: 9550702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide activates Rap1 and Ral in a Ras-independent manner.
    Mittar D; Sehajpal PK; Lander HM
    Biochem Biophys Res Commun; 2004 Sep; 322(1):203-9. PubMed ID: 15313192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival.
    Chien Y; White MA
    EMBO Rep; 2003 Aug; 4(8):800-6. PubMed ID: 12856001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells.
    de Gorter DJ; Reijmers RM; Beuling EA; Naber HP; Kuil A; Kersten MJ; Pals ST; Spaargaren M
    Blood; 2008 Apr; 111(7):3364-72. PubMed ID: 18227351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Ras and Ral in chemotactic migration of skeletal myoblasts.
    Suzuki J; Yamazaki Y; Li G; Kaziro Y; Koide H
    Mol Cell Biol; 2000 Jul; 20(13):4658-65. PubMed ID: 10848592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases.
    O Santos A; Parrini MC; Camonis J
    PLoS One; 2016; 11(5):e0154840. PubMed ID: 27149377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
    Zhang J; Lodish HF
    Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.
    Guin S; Ru Y; Wynes MW; Mishra R; Lu X; Owens C; Barn AE; Vasu VT; Hirsch FR; Kern JA; Theodorescu D
    J Thorac Oncol; 2013 Dec; 8(12):1492-501. PubMed ID: 24389431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.